|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | More anxious than depressed:prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus显示文摘Background Anxiety disorder, one of the highly disabling, prevalent and common mental disorders, is known to be more prevalent in persons with type 2 diabetes mellitus (T2DM) than the general population, and the comorbid presence of anxiety disorders is known to have an impact on the diabetes outcome and the quality of life. However, the information on the type of anxiety disorder and its prevalence in persons with T2DM is limited. Aims To assess the prevalence and correlates of anxiety disorder in people with type 2 diabetes in different countries. Methods People aged 18-65 years with diabetes and treated in outpatient settings were recruited in 15 countries and underwent a psychiatric interview with the Mini-International Neuropsychiatric Interview. Demographic and medical record data were collected. Results A total of 3170 people with type 2 diabetes (56.2% women;with mean (SD) duration of diabetes 10.01 (7.0) years) participated. The overall prevalence of anxiety disorders in type 2 diabetic persons was 18%;however, 2.8% of the study population had more than one type of anxiety disorder. The most prevalent anxiety disorders were generalised anxiety disorder (8.1%) and panic disorder (5.1%). Female gender, presence of diabetic complications, longer duration of diabetes and poorer glycaemic control (HbA1c levels) were significantly associated with comorbid anxiety disorder. A higher prevalence of anxiety disorders was observed in Ukraine, Saudi Arabia and Argentina with a lower prevalence in Bangladesh and India. Conclusions Our international study shows that people with type 2 diabetes have a high prevalence of anxiety disorders, especially women, those with diabetic complications, those with a longer duration of diabetes and poorer glycaemic control. Early identification and appropriate timely care of psychiatric problems of people with type 2 diabetes is warranted. | Santosh K Chaturvedi Shayanth Manche Gowda Helal Uddin Ahmed Fahad D Alosaimi Nicola Andreone Alexey Bobrov Viola Bulgari Giuseppe Carra Gianluca Castelnuovo Giovanni de Girolamo Tomasz Gondek Nikola Jovanovic Thummala Kamala Andrzej Ki Nebojsa Lalic Dusica Lecic-Tosevski Fareed Minhas Victoria Mutiso David Ndetei Golam Rabbani Suntibenchakul Somruk Sathyanarayana Srikanta Rizwan Taj Umberto Valentini Olivera Vukovic Wolfgang Wolwer Larry Cimino Arie Nouwen Cathy Lloyd Norman Sartorius | 2019 | General Psychiatry2019，32，4： | 11 |
| 2 | De novo autoimmune hepatitis in liver transplant: State-of-the-art review显示文摘In the two past decades, a number of communications, case-control studies, and retrospective reports have appeared in the literature with concerns about the development of a complex set of clinical, laboratory and histological characteristics of a liver graft dysfunction that is compatible with autoimmune hepatitis. The de novo prefix was added to distinguish this entity from a pre-transplant primary autoimmune hepatitis, but the globally accepted criteria for the diagnosis of autoimmune hepatitis have been adopted in the diagnostic algorithm. Indeed, de novo autoimmune hepatitis is characterized by the typical liver necroinflammation that is rich in plasma cells, the presence of interface hepatitis and the consequent laboratory findings of elevations in liver enzymes, increases in serum gamma globulin and the appearance of nonorgan specific auto-antibodies. Still, the overall features of de novo autoimmune hepatitis appear not to be attributable to a univocal patho-physiological pathway because they can develop in the patients who have undergone liver transplantation due to different etiologies. Specifically, in subjects with hepatitis C virus recurrence, an interferon-containing antiviral treatment has been indicated as a potential inception of immune system derangement. Herein, we attempt to review the currently available knowledge about de novo liver autoimmunity and its clinical management. | Ranka Vukotic Giovanni Vitale Antonia D'Errico-Grigioni Luigi Muratori Pietro Andreone | 2016 | World Journal of Gastroenterology2016，22，10： | 4 |
| 3 | Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial显示文摘 | M Degiuli M Sasako M Calgaro M Garino F Rebecchi M Mineccia D Scaglione D Andreone A Ponti F Calvo | 2004 | European Journal of Surgical Oncology2004，，3： | 2 |
| 4 | Magnetic shielding properties of YBa2Cu3O7-x thick films deposited on silver cylinders with the continuous detonation spray technique显示文摘 | Pavese F Bianco M Andreone D | 1992 | Physica C1992，204，12： | 1 |
| 5 | Telaprevir for retreatment of HCV infection 显示文摘 | Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Foeaccia R Younossi Z Foster GR Horban A Ferenci P Nevens F Mullhaupt B Pockros P Terg R Shouval D van Hoek B Weiland O Van Heeswijk R De Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M REALIZE Study Team | 2011 | N Engl J Med2011，364，25： | 1 |
| 6 | Long-term antiviral treatment for recurrent hepatitis C after liver transplantation显示文摘 | Valentina Rosa Bertuzzo Matteo Cescon Maria Cristina Morelli Paolo Di Gioia Mariarosa Tamè Stefania Lorenzini Pietro Andreone Giorgio Ercolani Massimo Del Gaudio Matteo Ravaioli Alessandro Cucchetti Alessandro Dazzi Antonietta D’Errico-Grigioni Antonio Da | 2012 | Digestive and Liver Disease2012，，10： | 1 |
| 7 | Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin显示文摘 | Granner D Andreone T Sasaki K | 1983 | Nature1983，305，5934： | 1 |
| 8 | Telaprevir for retreatment of HCV infection显示文摘 | Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Focaccia R Younossi Z Foster G R Horban A Ferenci P Nevens F Müllhaupt B Pockros P Terg R Shouval D Hoek B Weiland O Heeswijk R Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M | 2011 | N Engl J Med2011，364，25： | 1 |
| 9 | Genauigkeit von VirtualTouch Acoustic Radiation Force Impulse (ARFI) Imaging für die Ultraschalldiagnose einer Leberzirrhose显示文摘 | F. Piscaglia V. Salvatore R. Di Donato M. D’Onofrio S. Gualandi A. Gallotti E. Peri A. Borghi F. Conti G. Fattovich E. Sagrini A. Cucchetti P. Andreone L. Bolondi | 2011 | Ultraschall in Med2011，，： | 1 |
| 10 | Genauigkeit von VirtualTouch Acoustic Radiation Force Impulse (ARFI) Imaging für die Ultraschalldiagnose einer Leberzirrhose显示文摘 | F. Piscaglia V. Salvatore R. Di Donato M. D’Onofrio S. Gualandi A. Gallotti E. Peri A. Borghi F. Conti G. Fattovich E. Sagrini A. Cucchetti P. Andreone L. Bolondi | 2011 | Ultraschall in Med2011，，02： | 1 |
| 11 | Inhibition of decreases rt-anscription of the Phophoeno Lpyruvate carboxykinase gene by insulin显示文摘 | Granner D Andreone T Sasaki K | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员